Insights
The latest knowledge, ideas
and experiences driving our work
Filter by:
-
HMRC VAT repayment challenges and appeal rights: Holiday Booking Management Ltd v HMRC
Learn how HMRC VAT repayment claims can be challenged. Key insights from the 2026 tribunal ruling on appeal rights and credibility checks.
-
HMRC VAT guidance is not the law: Lessons from Clearwater Hampers v HMRC
Understand why HMRC VAT guidance not law can pose risks for businesses. Learn about Clearwater Hampers Ltd v HMRC case implications.
-
Your Wealth & Markets Update – May 2026
Explore PKF Your Wealth & Markets Update for insights on investment trends and strategies to navigate market fluctuations with confidence.
-
US market concentration: Risks, diversification and what it means for investors
Explore US market concentration and its impact on risk and diversification for investors in today’s concentrated equity market.
-
Can you predict markets? What 2025 and early 2026 reveal about forecasting
Uncover insights on whether you can predict markets. Learn how forecasts compare to actual outcomes in the financial landscape.
-
US taxpayers living in the UK: Key tax issues you cannot afford to overlook
Navigate the complexities of taxes as US taxpayers living in the UK. Understand the implications and seek specialist advice.
-
Inheritance Tax and succession planning: Funding education for future generations
Learn how inheritance tax and succession planning strategies, including discretionary trusts, can help families fund future education and protect wealth.
-
EDX Medical Group Plc
We have supported EDX Medical Group Plc on its admission to AIM and its move from the Aquis Stock Exchange
-
What are the alternatives if approved share schemes are unsuitable for insurance brokers?
Explore share scheme alternatives that can incentivise staff through equity participation while managing tax implications effectively.
-
UK insolvency statistics March 2026: what the latest figures mean for businesses and consumers
Explore the UK insolvency statistics for March 2026, revealing key trends and pressures affecting businesses this year.
-
AIM vs Main Market: London’s junior market has grown up
Explore the differences between AIM vs Main Market and how AIM supports innovative companies in capital fundraising.
-
UK VAT on clinical trials: HMRC’s treatment of free-of-charge medicines explained
HMRC is assessing VAT on free medicines used in UK clinical trials. Understand the risks for pharma companies and how to manage exposure.
